Dr Madawa Jayawardana
Honorary (Fellow)
The Sir Peter MacCallum Department of Oncology
34 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma
DOI: 10.1038/s41467-026-71134-32026
Journal article
Breast cancers arising in high mammographic density tissue harbor tumor-promoting immune profiles
DOI: 10.1038/s41523-025-00884-y2026
Journal article
Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC study
DOI: 10.1016/j.tranon.2026.1028712026
Journal article
Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression
DOI: 10.1002/path.64612025
Journal article
1637P FDG PET/CT response as a predictive biomarker of long-term outcomes and patterns of recurrence to immune checkpoint inhibitor (ICI) therapy in unresectable cutaneous melanoma
DOI: 10.1016/j.annonc.2025.08.22652025
Journal article
Feasibility and population exposure of 5-fluorouracil using therapeutic drug monitoring (PREDICT-5FU): A multicentre clinical trial
DOI: 10.1002/bcp.700062024
Research grants (other domestic)
Preclinical Validation of New Therapeutics for Low-Grade Serous Ovarian Cancer
RECENT SCHOLARLY WORKS
2025
Journal article
Abstract P5-10-30: Developing microenvironment-based prognostic biomarkers for early breast cancer
DOI: 10.1158/1557-3265.sabcs24-p5-10-302025
Journal article
Abstract P5-08-08: Predicting local recurrence in DCIS treated predominantly without radiation
DOI: 10.1158/1557-3265.sabcs24-p5-08-082024
Journal article
Stromal lymphocytes are associated with upgrade of B3 breast lesions
DOI: 10.1186/s13058-024-01857-y2024
Journal article
Pharmacogenetic-guided dosing for fluoropyrimidine (DPYD) and irinotecan (UGT1A1*28) chemotherapies for patients with cancer (PACIFIC-PGx): A multicenter clinical trial
DOI: 10.1111/cts.70083